FDA Approves Coartem Tablets to Treat Malaria

The U.S. Food and Drug Administration has approved Coartem tablets (artemether and lumefantrine) for the treatment of acute, uncomplicated malaria infections in adults and children weighing at least five kilograms (approximately 11 pounds). Coartem is not approved for the treatment of severe malaria nor to prevent malaria.

See the original post:
FDA Approves Coartem Tablets to Treat Malaria

No comments yet.
TOP